Table 1.
Characteristics of the thymoma and thymic carcinoma patients and non-neoplastic adult and pediatric control from cardiac surgery patients studied for WNT ligands, frizzled receptors and WNT inhibitors.
| Diagnosis | N | Age range (y) | Sex(m:f) | Stage(I–IV) | MG+ (%) |
|---|---|---|---|---|---|
| Type A | 9 | 36–81 | 4:5 | I (n = 4) II (n = 5) |
0 |
| Type AB | 25 | 26–77 | 15:10 | I (n = 18) II (n = 7) |
9 (40.9%) |
| Type B2 | 18 | 21–81 | 10:8 | I (n = 3) II (n = 6) III (n = 5) IV (n = 4) |
8 (44.4%) |
| Type B3 | 19 | 41–76 | 8:11 | I (n = 5) II (n = 4) III (n = 8) IV (n = 2) |
4 (21.05%) |
| TSQCC | 11 | 32–74 | 6:5 | I (n = 5) II (n = 3) III (n = 1) IV (n = 2) |
0 |
| CT | 6 | 0–10 | 4:2 | – | – |
| NT | 15 | 28–82 | 6:9 | – | – |